Drug Safety
Overview
Drug Safety is a peer-reviewed medical journal that focuses on the safe and effective use of medications. It publishes research articles, reviews, and case reports related to drug safety, adverse drug reactions, pharmacovigilance, and risk management. The journal aims to provide healthcare professionals and researchers with valuable insights to enhance patient safety and optimize drug therapy.
Details
Details
Abbr.
Drug Saf
Start
1990
End
Continuing
Frequency
Fifteen no. a year, 2001-
p-ISSN
0114-5916
e-ISSN
1179-1942
Country
New Zealand
Language
English
Specialties
Pharmacology
Toxicology
Toxicology
Metrics
Metrics
h-index / Ranks: 1640
140
SJR / Ranks: 2813
1204
CiteScore / Ranks: 2159
8.20
JIF / Ranks: 2095
4.2
Recent Articles
1.
Zekarias A, Meldau E, Bista S, Felix China J, Sandberg L
Drug Saf
. 2025 Mar;
PMID: 40088342
Introduction: Manual identification of case narratives with specific relevant information can be challenging when working with large numbers of adverse event reports (case series). The process can be supported with...
2.
Gerentes M, Lajnef M, Szoke A, Aouizerate B, Berna F, Clery M, et al.
Drug Saf
. 2025 Mar;
PMID: 40088341
Background: The life expectancy of patients with schizophrenia is reduced, partly due to cardiovascular diseases. Antipsychotics are associated with QT interval prolongation, which is a risk factor for arrhythmia and...
3.
Russell A, Lovett R, Vogeley A, Nunes D, McKelvie C, Middleton W, et al.
Drug Saf
. 2025 Mar;
PMID: 40075034
Background: Well-designed prescription medication information (PMI), defined as materials which communicate the essential information needed for a patient to safely and accurately self-administer a medication at or near the time...
4.
Hammad T, Davies S
Drug Saf
. 2025 Mar;
PMID: 40075033
Decision making in drug safety is a complex and iterative process that requires the integration of diverse evidence sources, scientific reasoning, and clinical judgment. Diverging opinions among stakeholders-including pharmacovigilance professionals,...
5.
Abate A, Poncato E, Barbieri M, Powell G, Rossi A, Peker S, et al.
Drug Saf
. 2025 Mar;
PMID: 40075032
Background: This study evaluated the feasibility of ChatGPT and Gemini, two off-the-shelf large language models (LLMs), to automate causality assessments, focusing on Adverse Events Following Immunizations (AEFIs) of myocarditis and...
6.
Smith M, Davis R, Bahri P, Saragoussi D, Nguyen V, Toyserkani G, et al.
Drug Saf
. 2025 Mar;
PMID: 40075031
Background: Significant methodological shortcomings have been documented to date in risk minimisation program evaluations for medicinal products, including overreliance on survey methods alone. Recently updated guidances from the Food and...
7.
Bjornsson R, Sigurdsson S, Arnarson D, Logason E, Bjornsson E
Drug Saf
. 2025 Mar;
PMID: 40072769
Introduction: Most epidemiological studies have found antibiotics to be the most common cause of drug-induced liver injury (DILI). It is unclear what the risk of DILI is associated with different...
8.
Smith L, Glaser M, Kempf D, Roman X, Artlich C, Patel M, et al.
Drug Saf
. 2025 Mar;
PMID: 40056291
The current practice of managing and sharing individual case safety reports (ICSRs) across the patient safety ecosystem, established in the 1960s, has become burdened with ICSR duplication and replication and...
9.
Al-Imam A, Lora R, Motyka M, Marletta E, Vezzaro M, Moczko J, et al.
Drug Saf
. 2025 Mar;
PMID: 40032797
Background: Psychedelics are gaining attention for their therapeutic potential in modern and personalized medicine. Online forums such as Erowid provide valuable user insights, but analyses of these experiences using natural...
10.